Wallace Akerley

27.5k citations
159 papers · 5.2k · 1 hit paper · h-index 36

Impact in

    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment
    • Brain Metastases and Treatment
    • Prostate Cancer Treatment and Research
  • Oncology top 1%
    • Lung Cancer Research Studies
    • Cancer Treatment and Pharmacology

Papers in

    • Lung Cancer Treatments and Mutations 60
    • Lung Cancer Diagnosis and Treatment 22
    • Brain Metastases and Treatment 16
    • Cancer Treatment and Pharmacology 24
    • Lung Cancer Research Studies 16
    • Colorectal Cancer Treatments and Studies 13

Wallace Akerley

151 papers receiving 5.1k citations

Wallace Akerley's Hit Papers

Randomized Phase II Study of Erlotinib Plus Tivantinib Versus Erlotinib Plus Placebo in Previously Treated Non–Small-Cell Lung Cancer 2011 · 324 citations
3240+5+10Years since publication100200300

Peers

Wallace Akerley
Comparison fields: 5 of 111
  • Pulmonary and Respiratory Medicine 2.4k
  • Oncology 1.9k
  • Hepatology 432
  • Otorhinolaryngology 125
  • Genetics 310
Replace Ashley E. Winkler with:
Ashley E. Winkler United States
F. Mornex France
Bernhard C. Pestalozzi Switzerland
Rogério Lilenbaum United States
Philip Bonomi United States
Shenhong Wu United States
Mark Kozloff United States
James D. Brierley Canada
Otilia Dalesio Netherlands
Edgar Ben‐Josef United States
Wallace Akerley relative to Ashley E. Winkler United States Ashley E. Winkler's profile →
Citations per field
00.5×11×
Ashley E. Winkler · 1×
Citations per year

Countries citing papers authored by Wallace Akerley

Since Specialization
Citations

This map shows the geographic impact of Wallace Akerley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wallace Akerley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wallace Akerley more than expected).

Fields of papers citing papers by Wallace Akerley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wallace Akerley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wallace Akerley. The network helps show where Wallace Akerley may publish in the future.

Co-authors

The 25 scholars most cited alongside Wallace Akerley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Wallace Akerley Line = papers co-authored together Wallace Akerley links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 159 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2000468
2 2007347
3
Randomized Phase II Study of Erlotinib Plus Tivantinib Versus Erlotinib Plus Placebo in Previously Treated Non–Small-Cell Lung Cancer
Hit paper breakdown →
2011324
4 2013318
5 2001272
6 1998233
7 2015214
8 2009191
9 1998190
10 1996140
11 1994116
12
Phase II trial of weekly paclitaxel and concurrent radiation therapy for locally advanced non-small cell lung cancer.
199892
13 201075
14 201271
15 199368
16 199767
17 201861
18 200260
19 200456
20 201355

About Wallace Akerley

Wallace Akerley is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 159 papers that have together received 5.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (60 papers), Cancer Treatment and Pharmacology (24 papers), Lung Cancer Diagnosis and Treatment (22 papers), Lung Cancer Research Studies (16 papers), Brain Metastases and Treatment (16 papers), Colorectal Cancer Treatments and Studies (13 papers), Cancer Genomics and Diagnostics (9 papers) and Hepatocellular Carcinoma Treatment and Prognosis (6 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.4k citations), Oncology (1.9k citations), Hepatology (432 citations), Otorhinolaryngology (125 citations) and Genetics (310 citations). Wallace Akerley has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include Howard Safran, Bernard F. Cole, Peter V. Kavanagh, Damian E. Dupuy, William W. Mayo-Smith, Ronald J. Zagoria, Michael Glantz, H. Choy, Joachim von Pawel and James E. Herndon. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Lung Cancer, Cancer Research and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact